| Key Financial Ratios of Glenmark Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
37.11 |
-53.22 |
10.53 |
33.37 |
34.38 |
|
| Diluted EPS (Rs.) |
37.11 |
-53.22 |
10.53 |
33.37 |
34.38 |
|
| Cash EPS (Rs.) |
54.33 |
-30.18 |
35.04 |
52.46 |
50.10 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
313.60 |
278.09 |
348.70 |
334.48 |
250.36 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
313.60 |
278.09 |
348.70 |
334.48 |
250.36 |
|
| Revenue from Operations/Share (Rs.) |
472.08 |
418.62 |
460.36 |
436.08 |
387.85 |
|
| PBDIT/Share (Rs.) |
87.36 |
72.13 |
91.97 |
88.14 |
75.65 |
|
| PBIT/Share (Rs.) |
70.13 |
51.50 |
70.31 |
70.89 |
59.93 |
|
| PBT/Share (Rs.) |
49.58 |
1.29 |
30.78 |
51.08 |
48.99 |
|
| Net Profit/Share (Rs.) |
37.11 |
-50.80 |
13.37 |
35.21 |
34.38 |
|
| NP After MI And SOA / Share (Rs.) |
37.11 |
-53.21 |
10.53 |
33.37 |
34.38 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
18.50 |
17.22 |
19.97 |
20.21 |
19.50 |
|
| PBIT Margin (%) |
14.85 |
12.30 |
15.27 |
16.25 |
15.45 |
|
| PBT Margin (%) |
10.50 |
0.30 |
6.68 |
11.71 |
12.63 |
|
| Net Profit Margin (%) |
7.86 |
-12.13 |
2.90 |
8.07 |
8.86 |
|
| NP After MI And SOA Margin (%) |
7.86 |
-12.71 |
2.28 |
7.65 |
8.86 |
|
| Return on Networth/Equity (%) |
11.83 |
-19.13 |
3.13 |
10.36 |
13.73 |
|
| Return on Capital Employed (%) |
19.62 |
17.01 |
13.84 |
16.13 |
14.83 |
|
| Return on Assets (%) |
6.52 |
-10.45 |
1.53 |
5.51 |
6.21 |
|
| Total Debt/Equity (X) |
0.25 |
0.13 |
0.46 |
0.40 |
0.66 |
|
| Asset Turnover Ratio (%) |
0.88 |
0.70 |
0.71 |
0.42 |
0.43 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.56 |
1.28 |
1.96 |
1.77 |
1.75 |
|
| Quick Ratio (X) |
1.05 |
0.84 |
1.37 |
1.23 |
1.21 |
|
| Inventory Turnover Ratio (X) |
4.81 |
1.15 |
1.31 |
1.85 |
1.85 |
|
| Dividend Payout Ratio (NP) (%) |
6.73 |
-4.69 |
23.73 |
7.49 |
7.27 |
|
| Dividend Payout Ratio (CP) (%) |
4.60 |
-7.66 |
7.76 |
4.93 |
4.99 |
|
| Earnings Retention Ratio (%) |
93.27 |
104.69 |
76.27 |
92.51 |
92.73 |
|
| Cash Earnings Retention Ratio (%) |
95.40 |
107.66 |
92.24 |
95.07 |
95.01 |
|
| Coverage Ratios |
|
|
|
|
|
|
| Interest Coverage Ratios (%) |
11.90 |
3.94 |
7.42 |
8.34 |
6.05 |
|
| Interest Coverage Ratios (Post Tax) (%) |
11.90 |
3.94 |
7.42 |
8.34 |
6.05 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
43,947.27 |
26,350.45 |
16,364.27 |
15,087.86 |
16,656.12 |
|
| EV/Net Operating Revenue (X) |
3.30 |
2.23 |
1.26 |
1.23 |
1.52 |
|
| EV/EBITDA (X) |
17.83 |
12.95 |
6.31 |
6.07 |
7.80 |
|
| MarketCap/Net Operating Revenue (X) |
3.26 |
2.29 |
1.01 |
1.01 |
1.20 |
|
| Retention Ratios (%) |
93.26 |
104.69 |
76.26 |
92.50 |
92.72 |
|
| Price/BV (X) |
4.91 |
3.44 |
1.38 |
1.37 |
1.86 |
|
| Price/Net Operating Revenue |
3.26 |
2.29 |
1.01 |
1.01 |
1.20 |
|
| Earnings Yield |
0.02 |
-0.06 |
0.02 |
0.08 |
0.07 |
|
Source : Dion Global Solutions Limited
